Bloomberg BusinessWeek, June 27, 2016

choi

(1) Xiaoqing Pi with Kevin Hamlin, Alone in China.
http://www.bloomberg.com/news/ar ... g-army-living-alone

Note:
(a) summary underneath the title in print: More of the young and elderly live by themselves
(b) "And in her one-bedroom apartment in the eastern city of Jining 山东省 济宁市, Hu Jiying, 81, sits on an old bed"
("Solitary young Chinese * * * also postpone having children * * * The rise of the single-person household * * * China had 66 million registered one-person homes in 2014, or 15 percent of all households, up from 6 percent in 1990, according to government data. (In the US, the number is 27 percent, the United Nations reports.) * * * As spouses [of parents] died, those parents often found themselves alone. * * * The [Chinese] government says it's expanded rural health care, encouraged private businesses to invest in retirement homes, and more than tripled the number of beds in nursing homes to 6.7 million. * * *  The divorce rate almost tripled from 2003 to 2014, to 2.7 divorces per 1,000 people"
(c) The print and online version are not the same (but keep the essence). The quotation in (b) is from the print.

(2) Bruce Einhorn, Taiwan's PC Makers Are Gunning for Gamers.
http://www.bloomberg.com/news/ar ... -gunning-for-gamers

Note:
(a) summary underneath the title in print: In Win Development's computer cases go from generic to cool
(b) "In Win Development, a Taiwanese producer of computer cases, is going after do-it-yourselfers. * * * Chairman Vincent Lai 賴文賢 董事長"

In Win Development, Inc  迎廣科技股份有限公司


(3) Natasha Khan, The Great Sea Turtle Migration.
http://www.bloomberg.com/news/ar ... s-a-shot-in-the-arm

Note:
(a) summary underneath the title in print: Chinese biopharma talent is leaving the Valley for Shanghai
(b) The print and online versions have the same content.
(c) "what had been an informal networking circle is now an exclusive industry group called BayHelix [Group 百华协会 (前 北核协会)] that counts among its members more than 300 senior executives active in the Chinese biopharma market. * * * Kewen Jin 主席金克文, chairman of BayHelix"
(d) "China is the second-biggest pharmaceutical market in the world after the US, according to IMS Institute for Healthcare Informatics, which expects the country's annual spending on drugs to reach $190 billion by 2020, up from an estimated $115 billion last year. To ensure that not all that money flows into the coffers of foreign companies, the Communist Party has enacted measures to foster national champions in life sciences. Pharma and biotech startups are eligible for tax incentives and rent subsidies, and their products qualify for expedited regulatory approval. 'We're at a tipping point in China,' says Ge Li 李革 [哥伦比亚大学有机化学博士], founder and chief executive officer of Shanghai-based WuXi App[T]ec (上海)药明康德新药开发有限公司 [2000- ]. * * * Steve Yang 首席运营官 杨青, a BayHelix co-founder who once worked at AstraZeneca and is now chief operating officer of WuXi"

IMS Health
https://en.wikipedia.org/wiki/IMS_Health
(Founded 1954 as Intercontinental Marketing Services ['hence the IMS name']; Headquarters Danbury, Connecticut)
(e) "Among the contenders is Zai Lab 再鼎医药 [2013- ], a two-year-old Shanghai company backed by about $140 million in funds from Sequoia Capital China and Qiming 启明创投 [2006- ], among others. Its founder, Samantha Du 杜莹, worked for Pfizer in Connecticut before returning to China. "